Literature DB >> 15128829

Inactivation of C5a anaphylatoxin by a peptide that is complementary to a region of C5a.

Emiko Fujita1, Imre Farkas, William Campbell, Lajos Baranyi, Hidechika Okada, Noriko Okada.   

Abstract

PL37 (RAARISLGPRCIKAFTE) is an antisense homology box peptide composed of aa 37-53 of C5a-anaphylatoxin and is considered to be the region essential for C5a function. Using a computer program, we designed the complementary peptides ASGAPAPGPAGPLRPMF (Pep-A) and ASTAPARAGLPRLPKFF (Pep-B). Pep-A bound to PL37 and to C5a with very slow dissociation as determined by analysis using surface plasmon resonance, whereas Pep-B failed to bind at all. C5a was inactivated by concentrations of 7 nM or more of Pep-A, and this concentration of Pep-A inhibited induction of intracellular Ca(2+) influx in neutrophils. Patch clamp electrophysiology experiments also showed the effectiveness of Pep-A in C5aR-expressing neuroblastoma cells. Furthermore, Pep-A administration prevented rats from C5a-mediated rapid lethal shock induced by an Ab to a membrane inhibitor of complement after LPS sensitization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128829     DOI: 10.4049/jimmunol.172.10.6382

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Autoantigen complementarity: a new theory implicating complementary proteins as initiators of autoimmune disease.

Authors:  William F Pendergraft; Barrak M Pressler; J Charles Jennette; Ronald J Falk; Gloria A Preston
Journal:  J Mol Med (Berl)       Date:  2004-12-11       Impact factor: 4.599

2.  Complement factor C5 but not C3 contributes significantly to hydrosalpinx development in mice infected with Chlamydia muridarum.

Authors:  Zhangsheng Yang; Turner Conrad; Zhou Zhou; Jianlin Chen; Pavel Dutow; Andreas Klos; Guangming Zhong
Journal:  Infect Immun       Date:  2014-05-19       Impact factor: 3.441

3.  Targeting the hedgehog signaling pathway with interacting peptides to Patched-1.

Authors:  Masafumi Nakamura; Haruo Tanaka; Yousuke Nagayoshi; Hiroshi Nakashima; Kosuke Tsutsumi; Takao Ohtsuka; Shunichi Takahata; Masao Tanaka; Hidechika Okada
Journal:  J Gastroenterol       Date:  2011-12-15       Impact factor: 7.527

4.  Progress and Trends in Complement Therapeutics.

Authors:  Daniel Ricklin; John D Lambris
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

5.  Deciphering the conformational landscape of few selected aromatic noncoded amino acids (NCAAs) for applications in rational design of peptide therapeutics.

Authors:  Lalita Mohan Behera; Manaswini Ghosh; Soumendra Rana
Journal:  Amino Acids       Date:  2022-06-20       Impact factor: 3.789

Review 6.  Inflammatory response in islet transplantation.

Authors:  Mazhar A Kanak; Morihito Takita; Faisal Kunnathodi; Michael C Lawrence; Marlon F Levy; Bashoo Naziruddin
Journal:  Int J Endocrinol       Date:  2014-04-30       Impact factor: 3.257

7.  C5a inhibitor protects against ischemia/reperfusion injury in rat small intestine.

Authors:  Eszter Tuboly; Mitsuru Futakuchi; Gabriella Varga; Daniel Érces; Tünde Tőkés; Andras Mészáros; József Kaszaki; Masumi Suzui; Masaki Imai; Alan Okada; Noriko Okada; Mihály Boros; Hidechika Okada
Journal:  Microbiol Immunol       Date:  2016-01       Impact factor: 1.955

Review 8.  Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis.

Authors:  Cheng-Jie Lin; Zhi-Gao Hu; Guan-Dou Yuan; Biao Lei; Song-Qing He
Journal:  World J Hepatol       Date:  2018-10-27

9.  C5a-Preactivated Neutrophils Are Critical for Autoimmune-Induced Astrocyte Dysregulation in Neuromyelitis Optica Spectrum Disorder.

Authors:  Paweł Piatek; Małgorzata Domowicz; Natalia Lewkowicz; Patrycja Przygodzka; Mariola Matysiak; Katarzyna Dzitko; Przemysław Lewkowicz
Journal:  Front Immunol       Date:  2018-07-23       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.